Skip to main content
Clinical Trials/NCT03388073
NCT03388073
Unknown
Not Applicable

Evaluation of Plant-based Nutritional Products on Stem Cells

Natural Immune Systems Inc1 site in 1 country24 target enrollmentJanuary 30, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stem Cell Mobilization
Sponsor
Natural Immune Systems Inc
Enrollment
24
Locations
1
Primary Endpoint
Change to stem cell numbers in blood circulation.
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this clinical study is to evaluate acute effects of plant-based nutritional extracts on adult stem cells, using a randomized double-blinded placebo-controlled cross-over study design.

Detailed Description

The purpose of this clinical study is to evaluate acute effects of plant-based nutritional extracts on adult stem cells, using a randomized double-blinded placebo-controlled cross-over study design. The research involves testing of acute effects of single doses of antioxidant-rich berry-based extracts, compared to a placebo. Blood samples are taken at baseline and 1 and 2 hours after consuming a single dose. The blood will be used to measure the numbers of different types of stem cells, to evaluate potential effects of stem cell mobilization and homing after consuming plant-based extracts. Adult stem cells are a type of cells that play a role in repairing and rejuvenating various tissue and organs in the body. At NIS Labs, we have shown that many types of plant-based nutritional products have small but reproducible and significant effects on stem cells, cytokines, and regenerative growth factors.

Registry
clinicaltrials.gov
Start Date
January 30, 2018
End Date
February 2, 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy adults 20-75 years of age;
  • Body weight higher than 110 pounds;
  • BMI below 35;

Exclusion Criteria

  • Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery not a problem);
  • Currently taking daily OTC medications, such as NSAIDs, Tylenol, allergy medications, and others (birth control and 81 mg aspirin not a problem);
  • Taking medications that affect the mind (such as anti-depressants) or nervous system (such as gabapentin);
  • Currently experiencing intense stressful events and life changes;
  • Actively depressed;
  • Experiencing sleep disturbances;
  • Working night shift;
  • Pregnant, nursing, or trying to become pregnant;
  • Food intolerances or allergies currently causing discomfort (such as Celiac's disease), due to ongoing inflammatory reactions that may negatively affect product absorption within the 3 hours of testing;
  • Food allergies related to ingredients in test product.

Outcomes

Primary Outcomes

Change to stem cell numbers in blood circulation.

Time Frame: Changes at 1 and 2 hours after consumption.

Flow cytometry evaluation of stem cell phenotype.

Secondary Outcomes

  • Change to numbers of circulating CD45- CD31+ CD309+ stem cells in blood circulation.(Changes at 1 and 2 hours after consumption.)
  • Change to numbers of circulating CD45dim CD34+ CD309+ stem cells in blood circulation.(Changes at 1 and 2 hours after consumption.)
  • Change to numbers of circulating CD45dim CD34+ stem cells in blood circulation.(Changes at 1 and 2 hours after consumption.)
  • Change to numbers of circulating CD45dim CD34+ CD309- stem cells in blood circulation.(Changes at 1 and 2 hours after consumption.)
  • Change to numbers of circulating CD45- CD90+ stem cells in blood circulation.(Changes at 1 and 2 hours after consumption.)

Study Sites (1)

Loading locations...

Similar Trials